Yasmin Farhatnia

Yasmin Farhatnia is currently an Honorary lecturer at UCL, Bioengineering Industrial Advisory Board Member at Queen Mary University of London, Medical Device Development Manager at Calla Lily Clinical Care, and Founder & CEO of Platinum Medica ltd. With a background as a Biological Safety Specialist at NAMSA, Farhatnia's expertise includes Nano-technology and regenerative medicine. Having completed a PhD in the same field at UCL, along with an MSc in Bioengineering and Medical Imaging, and a BSc (Hons) in Medical Engineering from Queen Mary University of London, Farhatnia's research projects have focused on the design and modification of polymeric covered stents for coronary artery applications.